116 related articles for article (PubMed ID: 37670707)
1. Research Progress of the Molecular Mechanism of Antithyroid Cancer Activity of Shikonin.
Sun C; Liao L
Curr Mol Pharmacol; 2024; 17():e040923220678. PubMed ID: 37670707
[TBL] [Abstract][Full Text] [Related]
2. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
Yang Q; Ji M; Guan H; Shi B; Hou P
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
[TBL] [Abstract][Full Text] [Related]
3. Shikonin Inhibites Migration and Invasion of Thyroid Cancer Cells by Downregulating DNMT1.
Zhang Y; Sun B; Huang Z; Zhao DW; Zeng Q
Med Sci Monit; 2018 Feb; 24():661-670. PubMed ID: 29389913
[TBL] [Abstract][Full Text] [Related]
4. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
[TBL] [Abstract][Full Text] [Related]
5. Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells.
Tang Q; Liu L; Zhang H; Xiao J; Hann SS
Drug Des Devel Ther; 2020; 14():577-589. PubMed ID: 32103900
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway.
Wang L; Tian Z; Yang Q; Li H; Guan H; Shi B; Hou P; Ji M
Oncotarget; 2015 Sep; 6(28):25917-31. PubMed ID: 26312762
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma.
Gong K; Zhang Z; Chen Y; Shu HB; Li W
Eur J Pharmacol; 2014 Sep; 738():142-52. PubMed ID: 24886888
[TBL] [Abstract][Full Text] [Related]
8. Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways.
Jing H; Sun W; Fan J; Zhang Y; Yang J; Jia J; Li J; Guo J; Luo S; Zheng Y
Mol Med Rep; 2016 Apr; 13(4):3009-16. PubMed ID: 26935874
[TBL] [Abstract][Full Text] [Related]
9. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
[TBL] [Abstract][Full Text] [Related]
10. Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway.
Bao C; Liu T; Qian L; Xiao C; Zhou X; Ai H; Wang J; Fan W; Pan J
J Cancer; 2021; 12(1):76-88. PubMed ID: 33391404
[No Abstract] [Full Text] [Related]
11. Enhancement of cisplatin-induced colon cancer cells apoptosis by shikonin, a natural inducer of ROS in vitro and in vivo.
He G; He G; Zhou R; Pi Z; Zhu T; Jiang L; Xie Y
Biochem Biophys Res Commun; 2016 Jan; 469(4):1075-82. PubMed ID: 26740178
[TBL] [Abstract][Full Text] [Related]
12. The apoptotic effect of shikonin on human papillary thyroid carcinoma cells through mitochondrial pathway.
Liu C; Yin L; Chen J; Chen J
Tumour Biol; 2014 Mar; 35(3):1791-8. PubMed ID: 24081676
[TBL] [Abstract][Full Text] [Related]
13. Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells.
Kim HJ; Hwang KE; Park DS; Oh SH; Jun HY; Yoon KH; Jeong ET; Kim HR; Kim YS
J Transl Med; 2017 May; 15(1):123. PubMed ID: 28569199
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic effect of Shikonin in rheumatoid arthritis by downregulating PI3K/AKT and MAPKs signaling pathways.
Liu C; He L; Wang J; Wang Q; Sun C; Li Y; Jia K; Wang J; Xu T; Ming R; Wang Q; Lin N
J Ethnopharmacol; 2020 Oct; 260():113039. PubMed ID: 32497675
[TBL] [Abstract][Full Text] [Related]
15. Shikonin Inhibits Cancer Through P21 Upregulation and Apoptosis Induction.
Wang F; Mayca Pozo F; Tian D; Geng X; Yao X; Zhang Y; Tang J
Front Pharmacol; 2020; 11():861. PubMed ID: 32581812
[TBL] [Abstract][Full Text] [Related]
16. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
17. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
[TBL] [Abstract][Full Text] [Related]
18. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
[TBL] [Abstract][Full Text] [Related]
19. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
20. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
